scispace - formally typeset
Open AccessJournal ArticleDOI

Child–Parent Familial Hypercholesterolemia Screening in Primary Care

Reads0
Chats0
TLDR
Child-parent screening was feasible in primary care practices at routine child immunization visits and 8 persons were identified as having positive screening results for familial hypercholesterolemia and were consequently at high risk for cardiovascular disease.
Abstract
BackgroundChild–parent screening for familial hypercholesterolemia has been proposed to identify persons at high risk for inherited premature cardiovascular disease. We assessed the efficacy and feasibility of such screening in primary care practice. MethodsWe obtained capillary blood samples to measure cholesterol levels and to test for familial hypercholesterolemia mutations in 10,095 children 1 to 2 years of age during routine immunization visits. Children were considered to have positive screening results for familial hypercholesterolemia if their cholesterol level was elevated and they had either a familial hypercholesterolemia mutation or a repeat elevated cholesterol level 3 months later. A parent of each child with a positive screening result for familial hypercholesterolemia was considered to have a positive screening result for familial hypercholesterolemia if he or she had the same mutation as the child or, if no mutations were identified, had the higher cholesterol level of the two parents. Re...

read more

Citations
More filters
Journal ArticleDOI

Atherosclerotic Cardiovascular Risk as an Emerging Priority in Pediatrics.

TL;DR: The underlying advances in cardiovascular risk assessment and management are discussed, and disease-associated factors that add to the traditional risk factors are reviewed, including inflammation, vascular, and endothelial factors.
Journal ArticleDOI

Persistent High Non-High-Density Lipoprotein Cholesterol in Early Childhood: A Latent Class Growth Model Analysis.

TL;DR: Patterns of non‐ HDL cholesterol are identified during early childhood, and family history of high cholesterol was associated most strongly with persistent high non‐HDL cholesterol.
Journal ArticleDOI

Improving detection and management of familial hypercholesterolaemia in Australian general practice

TL;DR: In this article, a two-stage pragmatic approach was employed to identify and manage patients with familial hypercholesterolaemia (FH) in primary healthcare, which is characterised by elevated low-density lipoprotein (LDL)-cholesterol and increased risk of cardiovascular disease.
Journal ArticleDOI

Past, Present, and Future of Familial Hypercholesterolemia Management

TL;DR: While it is possible to normalize LDL-C in people with FH, the disease unfortunately is still severely underdiagnosed and undertreated.
Journal ArticleDOI

Familial Hypercholesterolemia in Asia Pacific: A Review of Epidemiology, Diagnosis, and Management in the Region.

TL;DR: A literature review of the epidemiology, diagnosis, and management of familial hypercholesterolemia (FH) across the Asia-pacific region is presented in this article, which concludes with a Call to Action on FH for Asia Pacific to engage healthcare professionals, improve public awareness, and form national FH alliances, comprising all relevant healthcare professional organizations.
References
More filters
Journal ArticleDOI

Estimation of the Concentration of Low-Density Lipoprotein Cholesterol in Plasma, Without Use of the Preparative Ultracentrifuge

TL;DR: A method for estimating the cholesterol content of the serum low-density lipoprotein fraction (Sf0-20) is presented and comparison of this suggested procedure with the more direct procedure, in which the ultracentrifuge is used, yielded correlation coefficients of .94 to .99.
Journal ArticleDOI

Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society

TL;DR: There is an urgent worldwide need for diagnostic screening together with early and aggressive treatment of this extremely high-risk condition, familial hypercholesterolaemia.
Journal ArticleDOI

First and second trimester antenatal screening for Down's syndrome: the results of the Serum, Urine and Ultrasound Screening Study (SURUSS).

TL;DR: The matching criteria were gestation (using an ultrasound crown–rump length or biparietal diameter measurement), duration of storage, and centre, and Screening performance of the individual markers and combinations of markers together with maternal age was assessed.
Journal ArticleDOI

Efficacy and safety of statin therapy in Children with familial hypercholesterolemia: A randomized controlled trial

TL;DR: Two years of pravastatin therapy induced a significant regression of carotid atherosclerosis in children with familial hypercholesterolemia, with no adverse effects on growth, sexual maturation, hormone levels, or liver or muscle tissue.
Journal ArticleDOI

Familial Hypercholesterolemia in the Danish General Population: Prevalence, Coronary Artery Disease, and Cholesterol-Lowering Medication

TL;DR: The prevalence of familial hypercholesterolemia appears to be higher than commonly perceived in a general population of white Danish individuals, with at least half of affected subjects not receiving cholesterol-lowering medication.
Related Papers (5)